Literature DB >> 15466493

Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration.

Angéline Gradolatto1, Jean-Philippe Basly, Raymond Berges, Caroline Teyssier, Marie-Christine Chagnon, Marie-Héléne Siess, Marie-Chantal Canivenc-Lavier.   

Abstract

The metabolism of apigenin, a weak estrogenic flavonoid phytochemical, was investigated in the rat. After a single oral administration of radiolabeled apigenin, 51.0% of radioactivity was recovered in urine, 12.0% in feces, 1.2% in the blood, 0.4% in the kidneys, 9.4% in the intestine, 1.2% in the liver, and 24.8% in the rest of the body within 10 days. Sex differences appear with regard to the nature of compounds eliminated via the urinary route: immature male and female rats, like mature female rats, excreted a higher percentage of the mono-glucuronoconjugate of apigenin than the mono-sulfoconjugate of apigenin (10.0-31.6% versus 2.0-3.6%, respectively). Mature male rats excreted the same compounds in an inverse ratio (4.9% and 13.9%, respectively). Radioactivity appeared in the blood only 24 h after oral administration. Blood kinetics showed a high elimination half-time (91.8 h), a distribution volume of 259 ml, and a plasmatic clearance of 1.95 ml/h. All of the parameters calculated from these experiments suggested a slow metabolism of apigenin, with a slow absorption and a slow elimination phase. Thus, a possible accumulation of this flavonoid in the body can be hypothesized.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466493     DOI: 10.1124/dmd.104.000893

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  38 in total

Review 1.  Bioavailability challenges associated with development of anti-cancer phenolics.

Authors:  Song Gao; Ming Hu
Journal:  Mini Rev Med Chem       Date:  2010-06       Impact factor: 3.862

2.  Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study.

Authors:  Mitali Pandey; Parminder Kaur; Sanjeev Shukla; Ata Abbas; Pingfu Fu; Sanjay Gupta
Journal:  Mol Carcinog       Date:  2011-10-17       Impact factor: 4.784

3.  The Flavonoid Apigenin Is a Progesterone Receptor Modulator with In Vivo Activity in the Uterus.

Authors:  Matthew Dean; Julia Austin; Ren Jinhong; Michael E Johnson; Daniel D Lantvit; Joanna E Burdette
Journal:  Horm Cancer       Date:  2018-05-07       Impact factor: 3.869

4.  Antioxidant Activity and Teratogenicity Evaluation of Lawsonia Inermis in BALB/c Mice.

Authors:  Lobat Jafarzadeh; Neda Seifi; Najmeh Shahinfard; Mehrnoosh Sedighi; Soleiman Kheiri; Hedayatollah Shirzad; Mahmoud Rafieian-Kopaei
Journal:  J Clin Diagn Res       Date:  2015-05-01

Review 5.  Flavones: Food Sources, Bioavailability, Metabolism, and Bioactivity.

Authors:  Gregory L Hostetler; Robin A Ralston; Steven J Schwartz
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

6.  Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator (CFTR) Translation Product.

Authors:  Peter M Haggie; Puay-Wah Phuan; Joseph-Anthony Tan; Haijin Xu; Radu G Avramescu; Doranda Perdomo; Lorna Zlock; Dennis W Nielson; Walter E Finkbeiner; Gergely L Lukacs; Alan S Verkman
Journal:  J Biol Chem       Date:  2016-11-28       Impact factor: 5.157

Review 7.  Put "gender glasses" on the effects of phenolic compounds on cardiovascular function and diseases.

Authors:  Ilaria Campesi; Maria Marino; Manuela Cipolletti; Annalisa Romani; Flavia Franconi
Journal:  Eur J Nutr       Date:  2018-04-25       Impact factor: 5.614

8.  Proteomic study of granulocytic differentiation induced by apigenin 7-glucoside in human promyelocytic leukemia HL-60 cells.

Authors:  Eri Nakazaki; Soninkhishig Tsolmon; Junkyu Han; Hiroko Isoda
Journal:  Eur J Nutr       Date:  2011-11-24       Impact factor: 5.614

9.  Plant flavone apigenin: An emerging anticancer agent.

Authors:  Eswar Shankar; Aditi Goel; Karishma Gupta; Sanjay Gupta
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

10.  Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model.

Authors:  Faycal Guedj; Ashley E Siegel; Jeroen L A Pennings; Fatimah Alsebaa; Lauren J Massingham; Umadevi Tantravahi; Diana W Bianchi
Journal:  Am J Hum Genet       Date:  2020-10-23       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.